State of Tennessee, Department of Treasury’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.99M | Buy |
6,302
+1,923
| +44% | +$453K | 0.01% | 951 |
|
|
2026
Q1 | $874K | Sell |
4,379
-740
| -14% | -$146K | ﹤0.01% | 1254 |
|
|
2025
Q4 | $983K | Sell |
5,119
-2,671
| -34% | -$513K | ﹤0.01% | 1194 |
|
|
2025
Q3 | $1.38M | Buy |
7,790
+3,830
| +97% | +$569K | ﹤0.01% | 1062 |
|
|
2025
Q2 | $450K | Hold |
3,960
| – | – | ﹤0.01% | 1421 |
|
|
2025
Q1 | $416K | Sell |
3,960
-1,526
| -28% | -$173K | ﹤0.01% | 1455 |
|
|
2024
Q4 | $588K | Sell |
5,486
-1,694
| -24% | -$191K | ﹤0.01% | 1375 |
|
|
2024
Q3 | $719K | Sell |
7,180
-254
| -3% | -$25.6K | ﹤0.01% | 1329 |
|
|
2024
Q2 | $626K | Sell |
7,434
-2,043
| -22% | -$163K | ﹤0.01% | 1337 |
|
|
2024
Q1 | $693K | Sell |
9,477
-1,067
| -10% | -$78.7K | ﹤0.01% | 1281 |
|
|
2023
Q4 | $753K | Sell |
10,544
-1,006
| -9% | -$59.4K | ﹤0.01% | 1280 |
|
|
2023
Q3 | $692K | Hold |
11,550
| – | – | ﹤0.01% | 1201 |
|
|
2023
Q2 | $833K | Buy |
11,550
+959
| +9% | +$72K | ﹤0.01% | 1232 |
|
|
2023
Q1 | $779K | Sell |
10,591
-1,093
| -9% | -$77.7K | ﹤0.01% | 1206 |
|
|
2022
Q4 | $780K | Sell |
11,684
-7,045
| -38% | -$458K | ﹤0.01% | 1206 |
|
|
2022
Q3 | $1.01M | Buy |
18,729
+1,115
| +6% | +$65.5K | ﹤0.01% | 1090 |
|
|
2022
Q2 | $980K | Sell |
17,614
-110
| -0.6% | -$6.24K | ﹤0.01% | 1118 |
|
|
2022
Q1 | $1.24M | Buy |
17,724
+2,816
| +19% | +$204K | ﹤0.01% | 1101 |
|
|
2021
Q4 | $1.44M | Sell |
14,908
-288
| -2% | -$26.6K | 0.01% | 998 |
|
|
2021
Q3 | $1.32M | Buy |
15,196
+4,344
| +40% | +$336K | 0.01% | 1019 |
|
|
2021
Q2 | $888K | Hold |
10,852
| – | – | ﹤0.01% | 1204 |
|
|
2021
Q1 | $1.03M | Sell |
10,852
-900
| -8% | -$85.1K | ﹤0.01% | 1105 |
|
|
2020
Q4 | $729K | Sell |
11,752
-31,529
| -73% | -$1.8M | ﹤0.01% | 1172 |
|
|
2020
Q3 | $2.57M | Hold |
43,281
| – | – | 0.01% | 651 |
|
|
2020
Q2 | $3.02M | Buy |
+43,281
| New | +$2.74M | 0.01% | 596 |
|
|
2019
Q3 | – | Sell |
-29,691
| Closed | -$2.11M | – | 1612 |
|
|
2019
Q2 | $2.11M | Sell |
29,691
-2,694
| -8% | -$198K | 0.01% | 776 |
|
|
2019
Q1 | $2.54M | Hold |
32,385
| – | – | 0.01% | 741 |
|
|
2018
Q4 | $2.74M | Buy |
32,385
+10,216
| +46% | +$1.09M | 0.01% | 671 |
|
|
2018
Q3 | $3.8M | Sell |
22,169
-890
| -4% | -$134K | 0.02% | 637 |
|
|
2018
Q2 | $2.98M | Sell |
23,059
-806
| -3% | -$89.9K | 0.02% | 695 |
|
|
2018
Q1 | $2.46M | Sell |
23,865
-2,508
| -10% | -$248K | 0.01% | 742 |
|
|
2017
Q4 | $2.25M | Sell |
26,373
-480
| -2% | -$41.6K | 0.01% | 801 |
|
|
2017
Q3 | $2.28M | Sell |
26,853
-1,698
| -6% | -$134K | 0.01% | 790 |
|
|
2017
Q2 | $2.16M | Hold |
28,551
| – | – | 0.01% | 825 |
|
|
2017
Q1 | $1.89M | Buy |
28,551
+4,309
| +18% | +$283K | 0.01% | 899 |
|
|
2016
Q4 | $1.54M | Hold |
24,242
| – | – | 0.01% | 940 |
|
|
2016
Q3 | $1.54M | Buy |
24,242
+1,258
| +5% | +$92.4K | 0.01% | 888 |
|
|
2016
Q2 | $1.71M | Hold |
22,984
| – | – | 0.01% | 817 |
|
|
2016
Q1 | $1.53M | Buy |
22,984
+542
| +2% | +$32.9K | 0.01% | 810 |
|
|
2015
Q4 | $1.52M | Buy |
+22,442
| New | +$1.39M | 0.01% | 795 |
|
|
2015
Q3 | – | Sell |
-22,442
| Closed | -$1.41M | – | 1060 |
|
|
2015
Q2 | $1.41M | Sell |
22,442
-321
| -1% | -$17.5K | 0.01% | 867 |
|
|
2015
Q1 | $1.09M | Sell |
22,763
-961
| -4% | -$36.8K | 0.01% | 989 |
|
|
2014
Q4 | $788K | Buy |
+23,724
| New | +$772K | ﹤0.01% | 1098 |
|
Other funds holding LGND
JT
CAM
State of Tennessee, Department of Treasury's LGND Position: Q2 2026 in Review
State of Tennessee, Department of Treasury increased its Ligand Pharmaceuticals (LGND) stake by 44% in Q2 2026, buying an estimated $453K and bringing the position to 6,302 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #951.
State of Tennessee, Department of Treasury first reported a position in LGND in Q4 2014 and has held it in 43 quarters since. The position peaked at $3.8M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- State of Tennessee, Department of Treasury held 6,302 shares of Ligand Pharmaceuticals worth $1.99M as of Q2 2026.
- State of Tennessee, Department of Treasury bought 1,923 Ligand Pharmaceuticals shares in Q2 2026, an estimated $453K.
- Ligand Pharmaceuticals made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q2 2026, its #951 holding.
- State of Tennessee, Department of Treasury first reported a position in Ligand Pharmaceuticals in Q4 2014 and has held it in 43 quarters since.
- State of Tennessee, Department of Treasury's Ligand Pharmaceuticals position peaked at $3.8M in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2026, filed 14 Aug 2026.